Rivia SA

Skyvor Medical develops a cutting-edge digital health platform to expedite clinical research. Our Advanced Trial Operation Management (ATOM) System enables modern, patient-centric clinical trials, by seamlessly integration of EDC, eCOA, ePRO and other digital solutions onto one platform.  

FatiAbGen International is the Swiss subsidiary of FatiAbGen Co. Ltd., established in Korea in 2020. We engineer best in class antibodies tailored for multiple modalities such as ADCs and bi-specifics. We then develop targeted molecules to address high unmet need diseases in oncology and immunology.

Aspiring to be the Google Maps of the cell, Apricot Therapeutics, a spin-off from University of Zürich, is commercialising 4i imaging technology based on 17 years of development conducted at Pelkmans Lab, ETH Zürich and University of Zurich. Exclusivity on 2 patents for imaging + learning algorithms